Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Soligenix Receives FDA Protocol Clearance of Phase 3 Clinical Trial of SGX942

americanpharmaceuticalreviewMay 04, 2017

Tag: FDA , Protocol Clearance

PharmaSources Customer Service